Search

everythinglearnresearchcommunity

for

Search:↓

Men with genetic hair loss are more likely to have abnormal blood lipid levels, especially if the hair loss is severe.

Hair loss may increase heart disease risk.

There's no significant link between hair loss from male pattern baldness and early heart disease.

Early balding in men is linked to metabolic syndrome, so screening is important for prevention.

Korean patients with androgenetic alopecia may have a higher risk of heart-related health issues and could benefit from early heart screening and healthier lifestyles.

There's no clear link between female pattern hair loss, insulin resistance, and metabolic syndrome.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

The Spanish HSS-29 scale effectively measures changes in life quality due to female-pattern hair loss.

The Spanish version of the Hair Specific Skindex-29 is a reliable tool for measuring quality of life in Spanish-speaking women with hair loss.

In 2017, Spanish dermatologists most often prescribed minoxidil and finasteride for male hair loss, and minoxidil and oral contraceptives for premenopausal female hair loss.

Finasteride can help with hair loss and prostate issues but may negatively affect mood and the nervous system.

Photobiomodulation effectively improves skin and hair conditions with minimal side effects.

More clinical trials are needed to confirm if plant-based products can effectively treat COVID-19.

The Progressive Loss Risk Scale is a system that shows the long-term risks of hair restoration surgery, which can change based on factors like age and transplant area.

A new tool simplifies alopecia areata severity scoring but needs validation.

The PON1 192R gene variant is linked to a higher risk of psoriasis and heart disease in Western Mexico.

Impulsiveness is common across various psychiatric disorders and linked to many psychological symptoms.

The SBN system effectively assesses alopecia areata severity and predicts its course.

Higher PSA levels can indicate prostate cancer, but there's overlap with non-cancerous conditions.

New scale reliably assesses male hair loss with female pattern.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

Polygenic Score can help predict severe psoriasis and psoriatic arthritis.

The conclusion suggests that a new system for measuring hair loss could be created using automated analysis of photographs.

Naringin may help treat atopic dermatitis by reducing inflammation and improving the skin barrier.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.

The HSVS-A is an effective tool for quickly screening hair shedding in Asian women.